At a glance
ClinicalIndex Comparison RecordN/ACompleted· 203 enrolled
Drug / intervention
AQUACEL® Ag+ Extra™ +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Clinical Study to Compare the Performance of AQUACEL® Ag+ Extra™ and Cutimed® Sorbact® Dressing in the Management of Patients With Venous Leg Ulcers Over a 12-week Period
In Brief
A clinical study evaluating AQUACEL® Ag+ Extra™ and Cutimed® Sorbact® for Venous Leg Ulcer and Diabetic Foot. Completed, enrolled 203 participants across 18 sites in 3 countries.
Detailed Summary
Study is to provide evidence comparing AQUACEL® Ag+ Extra™ versus Cutimed® Sorbact® in the progression of wounds towards healing
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVenous Leg Ulcer, Diabetic Foot
CountriesColombia, Germany, United Kingdom
CollaboratorsNAMSA
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartDec 2022
First PostedJun 2023
Primary CompletionFeb 2024
TodayJul 2026
First PostedJun 7, 2023
Enrollment StartDec 5, 2022
Primary CompletionFeb 14, 2024
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 3.1 years ago
Interventions
AQUACEL® Ag+ Extra™device
Wound treatment with AQUACEL® Ag+ Extra™ dressing
Cutimed® Sorbact®device
Wound treatment with Cutimed® Sorbact® dressing